Vitamin E pills may cut heart disease risk in diabetics

By Stephen Daniells

- Last updated on GMT

Related tags: Vitamin e supplements, Myocardial infarction

Supplements of vitamin E may counteract complications in type-2
diabetics linked to an increased risk of heart disease, says a new
study from Italy.

Daily vitamin E supplements (500 International Units) were found to decrease levels of a protein associated with higher risk of atherosclerosis (hardening of the arteries) and ultimately cardiovascular disease in this study with 37 type-2 diabetics, published in the journal Nutrition, Metabolism and Cardiovascular Diseases​. "Vitamin E might therefore be effective in preventing early endothelial damage in type 2 diabetes mellitus, possibly representing a new tool for endothelial protection,"​ wrote lead author Arianna Vignini from Polytechnic University of Marche in Ancona. An estimated 19 million people are affected by diabetes in the EU 25, equal to four per cent of the total population. While the US document over 20 million people with diabetes, equal to seven per cent of the population. The total costs are thought to be as much as $132 billion, with $92 billion being direct costs from medication, according to 2002 American Diabetes Association figures. Type 2 diabetics are known to be at increased risk of cardiovascular disease, and this has been linked to a decrease in fibrinolysis - a process whereby the protein fibrin is broken down in the bloodstream. Fibrin plays an active role in coagulation of the blood. The decrease is fibrinolysis has been linked to increased production of plasminogen activator inhibitor type 1 (PAI-1), as is observed in diabetics, as well as cellular adhesion molecules, including the vascular cell adhesion molecule-1 (VCAM-1) and the intracellular adhesion molecule (ICAM). The researchers assigned the 24 men and 13 women to receive the daily vitamin E supplements for 10 weeks, and then followed them for a further 20 weeks. At the end of the study, Vignini and co-workers report that PAI-1 levels decreased by 32 per cent after ten weeks, and returned to approximate baseline levels after a further 20 weeks without supplementation. Moreover, VCAM-1 and ICAM levels decreased after 10 weeks, by 12 and 19 per cent, respectively. In addition, the production of nitric oxide (NO) - a molecule key for better blood flow - increased by about 50 per cent after ten weeks of vitamin E supplementation. Nitric oxide (NO) is a molecule used by the endothelium (cells lining the surface of blood vessels) to signal surrounding muscle to relax, leading to a reduction in blood pressure, reduced blood clotting and protection against myocardial infarction and strokes. Despite the positive results and implications for type-2 diabetics, the authors sounded a note of caution, stating that no control arm with a placebo was used, and the study was not double-blind and randomised. "Because of these limitations, our results can be considered highly suggestive of an effect of vitamin E supplementation on endothelial function in T2DM, but also indicates the need for further placebo-controlled studies on this issue,"​ they stated. In terms of vitamin E supplements and heart health for the wider population, a recent study reported that a higher dose - 3200 International Units - of vitamin E is needed to reduce oxidative stress in individuals at risk for cardiovascular disease, and this may be why previous trials using lower doses failed to show any benefits for the vitamin (Free Radical Biology and Medicine​, doi: 10.1016/j.freeradbiomed.2007.06.019). A number of epidemiological and animal studies have reported that antioxidants like vitamin E, vitamin C and beta-carotene might offer some protection against heart attack in individuals at risk. There are eight forms of vitamin E: four tocopherols (alpha, beta, gamma, delta) and four tocotrienols (alpha, beta, gamma, delta). Alpha-tocopherol (alpha-Toc) is the main source found in supplements and in the European diet, while gamma-tocopherol (gamma-Toc) is the most common form in the American diet. Source: Nutrition, Metabolism and Cardiovascular Diseases​ (Elsevier) Published on-line ahead of print, doi:10.1016/j.numecd.2007.01.002 "A study on the action of vitamin E supplementation on plasminogen activator inhibitor type 1 and platelet nitric oxide production in type 2 diabetic patients" ​Authors: A. Vignini, L. Nanetti, C. Moroni, R. Testa, C. Sirolla, M. Marra, S. Manfrini, D. Fumelli, F. Marcheselli, L. Mazzanti and R.A. Rabini

Related news

Show more

Related products

show more

WHERE THE WORLD IS GOING NEXT FOR VITAMIN D

WHERE THE WORLD IS GOING NEXT FOR VITAMIN D

PLT Health Solutions | 22-Jun-2022 | Product Brochure

Earthlight® Whole Food Vitamin D is a clean label ingredient that can help you create cutting-edge fortified foods and supplements. Low use levels mean...

Whitepaper: Optimizing immunity with vitamin D

Whitepaper: Optimizing immunity with vitamin D

DSM Nutritional Products | 16-Jun-2022 | Technical / White Paper

With vitamin D science evolving rapidly since the COVID-19 pandemic, our new whitepaper breaks down the latest research on the role of vitamin D in supporting...

Stronger Bones Begin with MenaQ7® Vitamin K2

Stronger Bones Begin with MenaQ7® Vitamin K2

Gnosis by Lesaffre | 06-Jun-2022 | Infographic

By activating the K-dependent protein Osteocalcin, Vitamin K2 as MK-7 enables the body to properly utilize calcium, binding it to the bone matrix.

A proactive approach to wellness.

A proactive approach to wellness.

ADM | 31-May-2022 | Case Study

Gain valuable insights into the attitudes, behaviors and priorities of the supplement consumer of the future with ADM’s detailed new case study. Inside,...

Related suppliers

Follow us

Products

View more

Webinars